JP2013523844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523844A5 JP2013523844A5 JP2013504064A JP2013504064A JP2013523844A5 JP 2013523844 A5 JP2013523844 A5 JP 2013523844A5 JP 2013504064 A JP2013504064 A JP 2013504064A JP 2013504064 A JP2013504064 A JP 2013504064A JP 2013523844 A5 JP2013523844 A5 JP 2013523844A5
- Authority
- JP
- Japan
- Prior art keywords
- ethoxy
- pharmaceutical composition
- asthma
- medicament
- copd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 239000003814 drug Substances 0.000 claims 14
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 12
- 208000006673 asthma Diseases 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- 208000015181 infectious disease Diseases 0.000 claims 8
- 208000024891 symptom Diseases 0.000 claims 8
- DKSVBVKHUICELN-UHFFFAOYSA-N 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole Chemical compound C=1C=C2C(OCC)=NOC2=CC=1OCCC(CC1)CCN1C1=CC=C(C)N=N1 DKSVBVKHUICELN-UHFFFAOYSA-N 0.000 claims 7
- -1 6-methyl-pyridazin-3-yl Chemical group 0.000 claims 4
- 208000037874 Asthma exacerbation Diseases 0.000 claims 4
- 230000006866 deterioration Effects 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000003928 nasal cavity Anatomy 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010901601A AU2010901601A0 (en) | 2010-04-15 | Compound for the treatment of respiratory condition or disease | |
| AU2010901601 | 2010-04-15 | ||
| PCT/AU2011/000434 WO2011127538A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523844A JP2013523844A (ja) | 2013-06-17 |
| JP2013523844A5 true JP2013523844A5 (enExample) | 2014-05-29 |
| JP6148618B2 JP6148618B2 (ja) | 2017-06-14 |
Family
ID=44788654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013504064A Active JP6148618B2 (ja) | 2010-04-15 | 2011-04-14 | 呼吸器の病態又は疾患の治療のための化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110257192A1 (enExample) |
| EP (1) | EP2558097B1 (enExample) |
| JP (1) | JP6148618B2 (enExample) |
| KR (1) | KR20130106267A (enExample) |
| CN (2) | CN105560245A (enExample) |
| AU (1) | AU2011241478B2 (enExample) |
| BR (1) | BR112012026244A2 (enExample) |
| CA (1) | CA2796207A1 (enExample) |
| EA (1) | EA025224B1 (enExample) |
| ES (1) | ES2647223T3 (enExample) |
| IL (1) | IL222244A0 (enExample) |
| MX (1) | MX2012011938A (enExample) |
| NZ (1) | NZ603040A (enExample) |
| SG (2) | SG184430A1 (enExample) |
| WO (1) | WO2011127538A1 (enExample) |
| ZA (1) | ZA201207696B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2909057C (en) | 2013-04-12 | 2022-03-22 | Obschestvo S Ogranichennoi Otvetstvennostiyu "Pharmenterprises" | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives |
| BR112016029942A2 (pt) | 2014-06-20 | 2017-08-22 | Aviragen Therapeutics Inc | composto, forma de base livre cristalina anidra, composição farmacêutica, método para fabricação de uma forma de base livre cristalina, método de tratamento de uma infecção viral, método de tratar, aliviar, prevenir ou reduzir os sintomas ou exacerbações de asma ou doença pulmonar obstrutiva crônica e método de tratamento de doença mão, pé e boca |
| WO2024192151A2 (en) * | 2023-03-13 | 2024-09-19 | Altesa BioSciences, Inc. | Method of dosing vapendavir to treat enterovirus infections |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| CA2475971A1 (en) * | 2002-02-14 | 2003-08-21 | Viropharma Incorporated | Methods of reducing rhinovirus contagion and related compositions |
| ATE399549T1 (de) * | 2003-02-21 | 2008-07-15 | Apodemus Ab | Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril |
| US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
| US20060069124A1 (en) * | 2004-09-07 | 2006-03-30 | Rao P S | Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases |
| AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| NZ590286A (en) * | 2008-05-27 | 2011-08-26 | Biota Scient Management | Phosphate and sulphate salts of 6-{ 2-[1-(6-methyl-3-pyrazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole |
| TW201016215A (en) * | 2008-07-17 | 2010-05-01 | Schering Corp | Compositions and uses of antiviral active pharmaceutical agents |
-
2011
- 2011-04-14 SG SG2012073565A patent/SG184430A1/en unknown
- 2011-04-14 BR BR112012026244A patent/BR112012026244A2/pt not_active IP Right Cessation
- 2011-04-14 WO PCT/AU2011/000434 patent/WO2011127538A1/en not_active Ceased
- 2011-04-14 MX MX2012011938A patent/MX2012011938A/es not_active Application Discontinuation
- 2011-04-14 CN CN201510982692.9A patent/CN105560245A/zh active Pending
- 2011-04-14 CN CN2011800192025A patent/CN102844032A/zh active Pending
- 2011-04-14 NZ NZ60304011A patent/NZ603040A/en not_active IP Right Cessation
- 2011-04-14 EP EP11768285.6A patent/EP2558097B1/en not_active Not-in-force
- 2011-04-14 SG SG10201502391WA patent/SG10201502391WA/en unknown
- 2011-04-14 CA CA2796207A patent/CA2796207A1/en not_active Abandoned
- 2011-04-14 EA EA201201416A patent/EA025224B1/ru not_active IP Right Cessation
- 2011-04-14 JP JP2013504064A patent/JP6148618B2/ja active Active
- 2011-04-14 KR KR1020127029232A patent/KR20130106267A/ko not_active Ceased
- 2011-04-14 AU AU2011241478A patent/AU2011241478B2/en not_active Ceased
- 2011-04-14 ES ES11768285.6T patent/ES2647223T3/es active Active
- 2011-04-15 US US13/087,624 patent/US20110257192A1/en not_active Abandoned
-
2012
- 2012-10-09 IL IL222244A patent/IL222244A0/en unknown
- 2012-10-12 ZA ZA2012/07696A patent/ZA201207696B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012520866A5 (enExample) | ||
| JP2011522816A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2013541583A5 (enExample) | ||
| JP2008044951A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| JP2016501865A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| JP2013522212A5 (enExample) | ||
| JP2014528901A5 (enExample) | ||
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| JP2012515184A5 (enExample) | ||
| JP2012502909A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2013518124A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| JP2013536837A5 (enExample) | ||
| JP2016507500A5 (enExample) | ||
| JP2013523844A5 (enExample) | ||
| JP2011500589A5 (enExample) | ||
| JP2010517992A5 (enExample) | ||
| JP2020500930A5 (enExample) | ||
| JP2009534367A5 (enExample) | ||
| JP2012502105A5 (enExample) | ||
| CN108472375A (zh) | 中重度流感的治疗方法 |